T. Rutherford
Nature Chemical Biology · 2009
A researcher in the Science corpus: 1 paper; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Papers from T. Rutherford's perspective
Ordered by how strongly the researchers T. Rutherford trusts endorse each paper. Same corpus, a different order for every researcher.
- The exploration of macrocycles for drug discovery — an underexploited structural class (Nature reviews. Drug discovery)
- Engineered antibody fragments and the rise of single domains (Nature Biotechnology)
- Substantial energetic improvement with minimal structural perturbation in a high affinity mutant antibody.
- Chemical remodelling of cell surfaces in living animals (Nature)
- Quantum Dots for Live Cells, in Vivo Imaging, and Diagnostics (Science)
- Antibody Multispecificity Mediated by Conformational Diversity (Science)
- An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus (Nature)
- Current development of mTOR inhibitors as anticancer agents (Nature reviews. Drug discovery)
- The natural functions of secondary metabolites. (Advances in Biochemical Engineering/Biotechnology)
- Natural products as sources of new drugs over the period 1981-2002. (Journal of Natural Products)
Their papers
- Phage-encoded combinatorial chemical libraries based on bicyclic peptides. (2009) — 637 citations